The fourth batch of drugs with differential pricing in Guangdong increased by 3.14% on average

Reporters yesterday (September 11) learned from the price bureau of Guangdong Province that the fourth batch of drugs with differential pricing in Guangdong had been published The list of drugs with differential pricing published this time covers 40 varieties, with an average increase of 3.14% The price covers 1-yuan So far, Guangdong has issued 133 varieties with differential pricing Due to the objection of qualification conditions of nine fourth batch of drugs with differential pricing, such as entecavir, the provincial Price Bureau decided to publicize the review results of these nine drugs from yesterday to 18th The so-called differential pricing refers to the behavior of setting or adjusting the price of specific drugs produced by qualified enterprises, which is different from the general drug pricing principle Based on the principle of uniform pricing, this pricing model will set different prices for specific drugs according to the quality of drugs According to the reporter, the average increase of 40 drugs with differential pricing announced this time is 3.14%, the highest is 6.97%, and the lowest is 0.29% Compared with the average increase of 5% for the third batch of varieties, the increase has narrowed down The highest selling price of 40 varieties publicized this time covers 1-yuan, among which the highest retail price of domestic tegio capsule is set as yuan a box, and the highest retail price of domestic Cefpiramide injection is set as yuan a piece According to the provincial Price Bureau, during the publicity period from May 31 to June 7, some enterprises put forward different feedback opinions and new evidence materials on the publicity results In the spirit of prudence and conscientiousness, the price bureau will supplement and reconsider the results of nine fourth batch of qualification documents of differential pricing drugs such as entecavir, carry out expert supplement and revaluation, and the members will reconsider and publicize the results The provincial Price Bureau reminded that from September 11, 2013 to September 18, 2013, if there is any objection from all walks of life, you can give feedback in real name, and submit the written opinion to Guangdong medical price review committee before September 18, 2013.